A novel CAR-T cell product targeting CD74 is an effective therapeutic approach in preclinical mantle cell lymphoma models

被引：0
|
作者：
Wing Keung Chan
Jessica Williams
Kinnari Sorathia
Betsy Pray
Kaled Abusaleh
Zehua Bian
Archisha Sharma
Ian Hout
Shamama Nishat
Walter Hanel
Shelby L. Sloan
Aneeq Yasin
Nathan Denlinger
Xiaoli Zhang
Natarajan Muthusamy
Sumithira Vasu
Marcos de Lima
Yiping Yang
Robert Baiocchi
Lapo Alinari
机构：
[1] The Ohio State University,Department of Internal Medicine, Division of Hematology, College of Medicine
[2] The Ohio State University,Department of Biomedical Informatics/Center for Biostatistics
来源：
Experimental Hematology & Oncology | / 12卷
关键词：
Mantle cell lymphoma; CD74; Chimeric antigen receptor;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [41] Development of Novel CAR-T Cell Therapy Targeting Disialoganglioside (GD2)
    Negishi, Kohei
    Akahori, Yasushi
    Seo, Naohiro
    Fujiwara, Hiroshi
    CANCER SCIENCE, 2024, 115 : 1882 - 1882
  • [42] Novel adapter CAR-T cell technology for precisely controllable multiplex cancer targeting
    Seitz, Christian M.
    Mittelstaet, Joerg
    Atar, Daniel
    Hau, Jana
    Reiter, Selina
    Illi, Clara
    Kieble, Verena
    Engert, Fabian
    Drees, Britta
    Bender, Giulia
    Krahl, Ann-Christin
    Knopf, Philipp
    Schroeder, Sarah
    Paulsen, Nikolas
    Rokhvarguer, Alexander
    Scheuermann, Sophia
    Rapp, Elena
    Mast, Anna-Sophia
    Rabsteyn, Armin
    Schleicher, Sabine
    Grote, Stefan
    Schilbach, Karin
    Kneilling, Manfred
    Pichler, Bernd
    Lock, Dominik
    Kotter, Bettina
    Dapa, Sandra
    Miltenyi, Stefan
    Kaiser, Andrew
    Lang, Peter
    Handgretinger, Rupert
    Schlegel, Patrick
    ONCOIMMUNOLOGY, 2021, 10 (01):
  • [43] Development of Novel CAR-T Cell Therapy Targeting Disialoganglioside (GD2)
    Negishi, Kohei
    Akahori, Yasushi
    Seo, Naohiro
    Wang, Linan
    Shiku, Hiroshi
    Fujiwara, Hiroshi
    CANCER SCIENCE, 2023, 114 : 1417 - 1417
  • [44] Novel Treatments for Mantle Cell Lymphoma: From Targeted Therapies to CAR T Cells
    Danielle Wallace
    Patrick M. Reagan
    Drugs, 2021, 81 : 669 - 684
  • [45] Novel Treatments for Mantle Cell Lymphoma: From Targeted Therapies to CAR T Cells
    Wallace, Danielle
    Reagan, Patrick M.
    DRUGS, 2021, 81 (06) : 669 - 684
  • [46] Anti-CD30 CAR-T Cell Therapy in Relapsed and Refractory Hodgkin Lymphoma
    Ramos, Carlos A.
    Grover, Natalie S.
    Beaven, Anne W.
    Lulla, Premal D.
    Wu, Meng-Fen
    Ivanova, Anastasia
    Wang, Tao
    Shea, Thomas C.
    Rooney, Cliona M.
    Dittus, Christopher
    Park, Steven I.
    Gee, Adrian P.
    Eldridge, Paul W.
    McKay, Kathryn L.
    Mehta, Birju
    Cheng, Catherine J.
    Buchanan, Faith B.
    Grilley, Bambi J.
    Morrison, Kaitlin
    Brenner, Malcolm K.
    Serody, Jonathan S.
    Dotti, Gianpietro
    Heslop, Helen E.
    Savoldo, Barbara
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (32) : 3794 - +
  • [47] CD19-targeting CAR-T cell treatment in patients with diffuse systemic sclerosis
    Avouac, Jerome
    LANCET RHEUMATOLOGY, 2025, 7 (02): : e74 - e75
  • [48] Outcome of patients with mantle cell lymphoma relapsing after autologous stem cell transplantation before availability of CAR-T treatment
    Mathys, A.
    Bacher, U.
    Banz, Y.
    Novak, U.
    Pabst, T.
    SWISS MEDICAL WEEKLY, 2020, : 19S - 19S
  • [49] A Novel Universal CD7-Targeted CAR-T Cell Therapy for Relapsed or Refractory T-Cell Acute Lymphoblastic Leukemia and T-Cell Lymphoblastic Lymphoma
    Zhang, Xian
    Zhou, Yali
    Yang, Junfang
    Li, Jingjing
    Qiu, Liyuan
    Ge, Wengang
    Pei, Bo
    Chen, Jie
    Han, Lu
    Ren, Jiangtao
    Lu, Peihua
    BLOOD, 2022, 140 : 4566 - 4567
  • [50] Starting T Cell and Cell Product Phenotype Are Associated with Durable Remission of Leukemia Following CD19 CAR-T Cell Immunotherapy
    Gardner, Rebecca
    Finney, Olivia
    Brakke, Hannah
    Rhea, Stephanie
    Hicks, Roxana
    Doolittle, Danielle
    Lopez, Marisa
    Orentas, Rimas J.
    Li, Daniel
    Jensen, Michael C.
    BLOOD, 2018, 132
12345